Related Experiment Video
Updated: Jul 17, 2026

Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression
Published on: March 17, 2020
[Pleomorphic Invasive Lobular Carcinoma Developed after Surgery for Simultaneous Ipsilateral Multiple Cancers]
Kenichi Sakurai1, Shuhei Suzuki, Keita Adachi
1Dept. of Breast and Endocrine Surgery, Nippon Dental University Hospital.
This case study highlights a rare instance of pleomorphic invasive lobular carcinoma developing after treatment for multiple breast cancers. Further research is needed to clarify the prognosis and treatment for this aggressive subtype.
Area of Science:
- Oncology
- Pathology
Background:
- A 54-year-old woman presented with a right breast lesion.
- Initial biopsy revealed invasive ductal carcinoma.
Purpose of the Study:
- To report a case of pleomorphic invasive lobular carcinoma (ILC) arising after treatment for multiple ipsilateral breast cancers.
- To discuss the diagnostic and therapeutic challenges posed by this rare presentation.
Main Methods:
- Initial diagnosis via needle biopsy.
- Surgical management including mastectomy and axillary lymph node dissection.
- Histopathological examination of resected tumors.
- Postoperative adjuvant therapies (chemotherapy, radiation, endocrine therapy).
- Subsequent diagnosis and surgical management of recurrent pleomorphic ILC.
Main Results:
- Initial presentation: Invasive ductal carcinoma (IDC) and invasive lobular carcinoma (ILC).
- Post-treatment recurrence: Pleomorphic ILC with multiple daughter nodules.
- Tumor characteristics: Both initial and recurrent tumors were ER/PgR negative and HER2 negative, with varying Ki-67 indices.
- Recurrent tumor: Pleomorphic ILC, 22 mm, ER negative, PgR positive, HER2 negative, Ki-67 25%.
Conclusions:
- Pleomorphic ILC can develop after treatment for other breast cancer types.
- The prognosis and optimal treatment strategy for pleomorphic ILC remain unclear, necessitating cautious management.
- This case underscores the importance of vigilant follow-up for patients with a history of multiple breast cancers.
More Related Videos
13:35Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
Published on: May 17, 2024
08:15A Hepatocellular Cancer Patient-Derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth
Published on: February 2, 2024
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...